RDY logo

RDY Long Term Liabilities

Annual Total Long Term Liabilities

$122.43 M
+$61.31 M+100.31%

March 31, 2024


Summary


Performance

RDY Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDYbalance sheetmetrics:

Quarterly Long Term Liabilities

$321.08 M
-$5.89 M-1.80%

December 31, 2024


Summary


Performance

RDY Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDYbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

RDY Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+100.3%+78.7%
3 y3 years-0.5%+78.7%
5 y5 years-66.7%+407.0%

RDY Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.5%+100.3%-1.8%+472.2%
5 y5-year-66.7%+108.0%-1.8%+472.2%
alltimeall time-80.4%+608.8%-50.2%+2005.5%

Dr Reddys Laboratories Limited Long Term Liabilities History

DateAnnualQuarterly
Dec 2024
-
$321.08 M(-1.8%)
Sep 2024
-
$326.97 M(+81.9%)
Jun 2024
-
$179.71 M(+37.1%)
Mar 2024
$122.43 M(+100.3%)
$131.05 M(-4.0%)
Dec 2023
-
$136.46 M(+16.4%)
Sep 2023
-
$117.21 M(+6.7%)
Jun 2023
-
$109.83 M(+79.7%)
Mar 2023
$61.12 M(-44.1%)
$61.12 M(+8.9%)
Dec 2022
-
$56.11 M(-3.1%)
Sep 2022
-
$57.90 M(-4.7%)
Jun 2022
-
$60.77 M(-44.4%)
Mar 2022
$109.26 M(-11.2%)
$109.26 M(-7.9%)
Dec 2021
-
$118.62 M(+1.7%)
Sep 2021
-
$116.65 M(+1.1%)
Jun 2021
-
$115.43 M(-6.2%)
Mar 2021
$123.05 M(+109.1%)
$123.05 M(-0.5%)
Dec 2020
-
$123.61 M(-3.3%)
Sep 2020
-
$127.83 M(+0.7%)
Jun 2020
-
$126.88 M(+115.6%)
Mar 2020
$58.86 M(-84.0%)
$58.86 M(-7.1%)
Dec 2019
-
$63.33 M(-76.3%)
Sep 2019
-
$267.58 M(-6.8%)
Jun 2019
-
$287.01 M(-21.9%)
Mar 2019
$367.61 M(-18.7%)
$367.61 M(-9.5%)
Dec 2018
-
$406.13 M(-6.4%)
Sep 2018
-
$434.11 M(-1.0%)
Jun 2018
-
$438.63 M(-3.0%)
Mar 2018
$452.38 M(+172.2%)
$452.38 M(-0.6%)
Dec 2017
-
$455.28 M(-0.3%)
Sep 2017
-
$456.54 M(+0.5%)
Jun 2017
-
$454.32 M(+173.4%)
Mar 2017
$166.18 M(-24.8%)
$166.18 M(+3.9%)
Dec 2016
-
$159.96 M(-31.7%)
Sep 2016
-
$234.33 M(+11.2%)
Jun 2016
-
$210.65 M(-4.6%)
Mar 2016
$220.90 M(-29.0%)
$220.90 M(-7.8%)
Dec 2015
-
$239.59 M(+1.9%)
Sep 2015
-
$235.09 M(-15.3%)
Jun 2015
-
$277.54 M(-10.8%)
Mar 2015
$311.25 M(-26.5%)
$311.25 M(-5.2%)
Dec 2014
-
$328.19 M(-10.5%)
Sep 2014
-
$366.72 M(-7.7%)
Jun 2014
-
$397.45 M(-6.2%)
Mar 2014
$423.75 M(+49.0%)
$423.75 M(-0.8%)
Dec 2013
-
$427.05 M(-4.2%)
Sep 2013
-
$445.67 M(+64.2%)
Jun 2013
-
$271.46 M(-4.5%)
Mar 2013
$284.39 M
$284.39 M(-23.2%)
DateAnnualQuarterly
Dec 2012
-
$370.28 M(-0.9%)
Sep 2012
-
$373.69 M(+8.5%)
Jun 2012
-
$344.43 M(-4.8%)
Mar 2012
$361.62 M(+101.8%)
$361.62 M(+1.5%)
Dec 2011
-
$356.40 M(+112.8%)
Sep 2011
-
$167.44 M(-8.0%)
Jun 2011
-
$182.07 M(+1.6%)
Mar 2011
$179.20 M(-4.2%)
$179.20 M(+184.2%)
Dec 2010
-
$63.06 M(-44.8%)
Sep 2010
-
$114.30 M(-23.3%)
Jun 2010
-
$149.11 M(-20.3%)
Mar 2010
$187.08 M(-37.6%)
$187.08 M(-14.5%)
Dec 2009
-
$218.87 M(-19.5%)
Sep 2009
-
$271.80 M(-19.4%)
Jun 2009
-
$337.30 M(+12.5%)
Mar 2009
$299.78 M(-35.6%)
$299.78 M(-10.8%)
Dec 2008
-
$336.13 M(-9.0%)
Sep 2008
-
$369.55 M(-13.6%)
Jun 2008
-
$427.88 M(-8.1%)
Mar 2008
$465.77 M(-22.5%)
$465.77 M(+3.3%)
Dec 2007
-
$450.78 M(-3.9%)
Sep 2007
-
$469.32 M(-5.0%)
Jun 2007
-
$494.27 M(-17.7%)
Mar 2007
$600.74 M(-3.9%)
$600.74 M(+8.0%)
Dec 2006
-
$556.30 M(-13.7%)
Sep 2006
-
$644.25 M(+2.1%)
Jun 2006
-
$630.72 M(+0.9%)
Mar 2006
$624.85 M(+3517.4%)
$624.85 M(+2889.8%)
Dec 2005
-
$20.90 M(+23.6%)
Sep 2005
-
$16.90 M(-11.2%)
Jun 2005
-
$19.04 M(+10.2%)
Mar 2005
$17.27 M(-26.4%)
$17.27 M(+13.3%)
Dec 2004
-
$15.25 M(-15.7%)
Sep 2004
-
$18.10 M(+3.3%)
Jun 2004
-
$17.51 M(-25.3%)
Mar 2004
$23.46 M(-1.6%)
$23.46 M(-0.5%)
Dec 2003
-
$23.57 M(-4.5%)
Sep 2003
-
$24.69 M(+3.1%)
Jun 2003
-
$23.94 M(+0.4%)
Mar 2003
$23.84 M(+1.3%)
$23.84 M(-15.1%)
Dec 2002
-
$28.09 M(+1.9%)
Sep 2002
-
$27.55 M(-0.7%)
Jun 2002
-
$27.74 M(+17.8%)
Mar 2002
$23.54 M(-48.3%)
$23.54 M(-8.6%)
Dec 2001
-
$25.76 M(+9.3%)
Sep 2001
-
$23.57 M(+8.6%)
Jun 2001
-
$21.70 M
Mar 2001
$45.57 M
-

FAQ

  • What is Dr Reddys Laboratories Limited annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited annual total long term liabilities year-on-year change?
  • What is Dr Reddys Laboratories Limited quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited quarterly long term liabilities year-on-year change?

What is Dr Reddys Laboratories Limited annual total long term liabilities?

The current annual total long term liabilities of RDY is $122.43 M

What is the all time high annual total long term liabilities for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high annual total long term liabilities is $624.85 M

What is Dr Reddys Laboratories Limited annual total long term liabilities year-on-year change?

Over the past year, RDY annual total long term liabilities has changed by +$61.31 M (+100.31%)

What is Dr Reddys Laboratories Limited quarterly total long term liabilities?

The current quarterly long term liabilities of RDY is $321.08 M

What is the all time high quarterly long term liabilities for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high quarterly total long term liabilities is $644.25 M

What is Dr Reddys Laboratories Limited quarterly long term liabilities year-on-year change?

Over the past year, RDY quarterly total long term liabilities has changed by +$141.37 M (+78.67%)